Cargando…
Complement sC5b-9 and CH50 increase the risk of cancer-related mortality in patients with non-small cell lung cancer
Objectives: Immunologic dysfunction occurred in most of patients with non-small cell lung cancer (NSCLC), which worsened the overall survival (OS) of patients. Complement activation plays a significant role in abnormal activation of immune system. However, the prognostic value of complement componen...
Autores principales: | Li, Jing, Cao, Zhijun, Mi, Lijie, Xu, Zhihua, Wu, Xiangmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646172/ https://www.ncbi.nlm.nih.gov/pubmed/33193878 http://dx.doi.org/10.7150/jca.46721 |
Ejemplares similares
-
Prognostic value of miR-219-5p in relation to mortality in patients with small cell lung cancer: a retrospective, observational cohort study in China
por: Wu, Xiangmei, et al.
Publicado: (2023) -
Elevated levels of C3, C4, and CH50 of the complement system in ICU and non‐ICU patients with COVID‐19
por: Bagherimoghaddam, Ahmad, et al.
Publicado: (2022) -
Using ChEMBL to Complement Schistosome Drug Discovery
por: Padalino, Gilda, et al.
Publicado: (2023) -
Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue Infection
por: Hedetoft, Morten, et al.
Publicado: (2021) -
$\pi^{+}$ production in CH$_{2}$ by SC 610 MeV external protons
por: Gilly, L, et al.
Publicado: (1965)